Brazil Buys 10 Million Sputnik V Vaccine Doses

The Russian Direct Investment Fund (RDIF) and one of Brazil's leading pharmaceutical companies, União Química, announced on January 13, 2021, that they have agreed to supply 10 million doses of the Sputnik V vaccine in the first quarter of 2021 to Brazil.

Kirill Dmitriev, CEO of the RDIF, said in a press statement, “On our end, we are ready for full-scale cooperation on supplies and production to begin the vaccination of the population in Brazil as soon as possible. Sputnik V is a safe and effective vaccine created on a proven and well-researched human adenoviral vectors platform. Several countries in Latin America are already vaccinating people with Sputnik V."

Sputnik V has been approved under emergency use authorization procedure in many countries, including, but not limited to Argentina, Bolivia, Algeria, Serbia, and Palestine. Furthermore, Sputnik V's local production has been launched in Brazil, says the RDIF.

The Sputnik V (Gam-COVID-Vac) is an adenoviral-based vaccine against the SARS-CoV-2 coronavirus. Sputnik V uses a weakened virus to deliver small parts of a pathogen and stimulate an immune response.